ARTICLE | Company News
EC approves Shire's Vpriv
August 27, 2010 12:54 AM UTC
The European Commission approved an MAA from Shire plc (LSE:SHP; NASDAQ:SHPGY) for Vpriv velaglucerase alfa to treat Type I Gaucher's disease. FDA approved the glucocerebrosidase enzyme replacement th...